← Leaderboards
Graham Douglas Hogg
Washington University
$167,870
Attributed
$167,870
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $52.7K · FY2020–23$100K$75K$50K$25K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$167,870 · 1
By mechanism
F30$167,870 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- David G Denardo$14,438,310
- Kian H Lim$7,461,157
- Ryan C Fields$14,321,445
- Wilson Barry Edwards$3,185,853
- Eynav Yafit Klechevsky$3,791,522
Others in their field
Other Emerging Leaders on “Dendritic Cells”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Gary Fanger · Rise Therapeutics, Llc$11,457,164
- Norbert Pardi · University Of Pennsylvania$9,130,651
- Garcia-Sastre Adolfo · Icahn School Of Medicine At Mount Sinai$8,560,974
- Dawn C Ward · University Of California Los Angeles$7,282,377
- Kevin Wiehe · Duke University$7,046,198
Research focus
Dendritic CellsCytokineCtla4 GeneCytotoxic T-LymphocytesAnti-Pd-1Anti-Ctla4AgonistAntibodiesAntigen-Presenting CellsCancer TherapyCareerCd80 GeneCell CountAutomobile DrivingAntigen PresentationCell TransformationCheckpoint TherapyChemokineClinicClinical TrialsCombatCombination ImmunotherapyCombined Modality TherapyDensity
Grant awards (4)
Harnessing Dendritic Cells as a Novel Therapy in Pancreatic Ductal Adenocarcinoma$52,694
F30 · FY2023 · CA · contact PI
Harnessing Dendritic Cells as a Novel Therapy in Pancreatic Ductal Adenocarcinoma$51,752
F30 · FY2022 · CA · contact PI
Harnessing Dendritic Cells as a Novel Therapy in Pancreatic Ductal Adenocarcinoma$31,970
F30 · FY2021 · CA · contact PI
Harnessing Dendritic Cells as a Novel Therapy in Pancreatic Ductal Adenocarcinoma$31,454
F30 · FY2020 · CA · contact PI